Vascularized Composite Allograft Rejection Is Delayed by Intrajejunal Treatment with Donor Splenocytes without Concomitant Immunosuppressants

Background. Mucosal or oral tolerance, an established method for inducing low-risk antigen-specific hyporesponsiveness, has not been investigated in vascularized composite allograft (VCA) research. We studied its effects on recipient immune responses and VCA rejection. Methods. Lewis rats (n = 12; T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallace, Christopher Glenn, Yen, Chia-Hung, Yang, Hsiang-Chen, Lin, Chun-Yen, Wu, Ren-Chin, Huang, Wei-Chao, Lin, Jeng-Yee, Wei, Fu-Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514848/
https://www.ncbi.nlm.nih.gov/pubmed/23227087
http://dx.doi.org/10.1155/2012/704063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514848/
https://www.ncbi.nlm.nih.gov/pubmed/23227087
http://dx.doi.org/10.1155/2012/704063

Ejemplares similares